Patent · US Active

Antiviral nucleosides

US8236779B2 · kind B2 · utility

27Cited by

2References

15Claims

0Family size

Assignee

Roche Palo Alto LLC · US

Inventors

Han Ma · Passaic, US
Keshab Sarma · Sunnyvale, US
David Bernard Smith · San Mateo, US

Key dates

Filing date	Jan 26, 2011
Grant date	Aug 7, 2012
Priority date	—
Expiry date	Jan 26, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds having the formula I wherein R1, R2 and R3 are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.